GIPR and cardiovascular disorder: We previously reported that the E354Q variant of Gastric Inhibitory peptide receptor (GIPR), which is associated with an increased incidence of insulin resistance, type 2 diabetes, and cardiovascular disease in humans, undergoes exaggerated downregulation from the plasma membrane after stimulation with GIP [49].